Wolfgang C. Winkelmayer, MD, ScD
Publication Details
-
Anticoagulation for atrial fibrillation in patients on dialysis: are the benefits worth the risks?
Curr Opin Nephrol Hypertens. 2012; (6): 600-6
Atrial fibrillation is common among patients with end-stage renal disease undergoing hemodialysis. Although oral anticoagulation is recommended for stroke prevention in most patients with atrial fibrillation, limited evidence is available to guide treatment in hemodialysis patients with this arrhythmia. We summarize the available evidence on the epidemiology of atrial fibrillation in dialysis patients and review the data on the effectiveness of oral anticoagulation in this population.
Help